A Study of ADR-001 in Patients With Liver Cirrhosis

NCT03254758 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Decompensated Liver Cirrhosis

Interventions

BIOLOGICAL: Mesenchymal stem cell

Sponsor

Rohto Pharmaceutical Co., Ltd.